Ghosh S, Majumder P B, Sen Mandi S
Bose Institute, Kolkata, India.
Genet Mol Res. 2011 Feb 8;10(1):218-29. doi: 10.4238/vol10-1gmr1154.
The Zingiber genus, which includes the herbs known as gingers, commonly used in cooking, is well known for its medicinal properties, as described in the Indian pharmacopoeia. Different members of this genus, although somewhat similar in morphology, differ widely in their pharmacological and therapeutic properties. The most important species of this genus, with maximal therapeutic properties, is Zingiber officinale (garden ginger), which is often adulterated with other less-potent Zingiber sp. There is an existing demand in the herbal drug industry for an authentication system for the Zingiber sp in order to facilitate their commercial use as genuine phytoceuticals. To this end, we used amplified fragment length polymorphism (AFLP) to produce DNA fingerprints for three Zingiber species. Sixteen collections (six of Z. officinale, five of Z. montanum, and five of Z. zerumbet) were used in the study. Seven selective primer pairs were found to be useful for all the accessions. A total of 837 fragments were produced by these primer pairs. Species-specific markers were identified for all three Zingiber species (91 for Z. officinale, 82 for Z. montanum, and 55 for Z. zerumbet). The dendogram analysis generated from AFLP patterns showed that Z. montanum and Z. zerumbet are phylogenetically closer to each other than to Z. officinale. The AFLP fingerprints of the Zingiber species could be used to authenticate Zingiber sp-derived drugs and to resolve adulteration-related problems faced by the commercial users of these herbs.
姜属植物,包括烹饪中常用的姜类草本植物,如印度药典所述,以其药用特性而闻名。该属的不同成员,尽管形态上有些相似,但其药理和治疗特性差异很大。该属中具有最大治疗特性的最重要物种是姜(姜科姜属植物),它经常被其他效力较低的姜属植物掺杂。草药行业目前需要一种姜属植物的鉴定系统,以便将其作为真正的植物药进行商业使用。为此,我们使用扩增片段长度多态性(AFLP)技术为三种姜属植物生成DNA指纹图谱。本研究使用了16个样本(6个姜样本、5个山姜样本和5个艳山姜样本)。发现7对选择性引物对所有样本都有用。这些引物对共产生了837个片段。为所有三种姜属植物鉴定出了物种特异性标记(姜有91个、山姜有82个、艳山姜有55个)。从AFLP图谱生成的树状图分析表明,山姜和艳山姜在系统发育上彼此比与姜更接近。姜属植物的AFLP指纹图谱可用于鉴定姜属植物衍生的药物,并解决这些草药商业用户面临的掺假相关问题。